{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T14:24:24Z","timestamp":1709735064453},"reference-count":39,"publisher":"Japanese Society of Toxicologic Pathology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1293\/tox.2022-0003","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T22:09:38Z","timestamp":1653862178000},"page":"299-311","source":"Crossref","is-referenced-by-count":1,"title":["Changes in 5-Fluorouracil-induced external granular cell damage during the          time-course of the developing cerebellum of infant rats"],"prefix":"10.1293","volume":"35","author":[{"given":"Yuko","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Pathology Division, Gotemba Laboratories, BoZo Research              Center Inc., 1284 Kamado, Gotemba, Shizuoka 412-0039, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Saito","sequence":"additional","affiliation":[{"name":"Pathology Division, Gotemba Laboratories, BoZo Research              Center Inc., 1284 Kamado, Gotemba, Shizuoka 412-0039, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Takagi","sequence":"additional","affiliation":[{"name":"Pathology Division, Gotemba Laboratories, BoZo Research              Center Inc., 1284 Kamado, Gotemba, Shizuoka 412-0039, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Pathology Division, Gotemba Laboratories, BoZo Research              Center Inc., 1284 Kamado, Gotemba, Shizuoka 412-0039, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Pathology Division, Gotemba Laboratories, BoZo Research              Center Inc., 1284 Kamado, Gotemba, Shizuoka 412-0039, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Longley              DB,                Harkin              DP, and                Johnston              PG.            5-fluorouracil: mechanisms of action and clinical            strategies. Nat Rev Cancer. 3:            330\u2013338. 2003.","DOI":"10.1038\/nrc1074"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Inoue              T, and                Horii              I. Effects on            fetal thymocyte populations and postnatal T-cell-dependent immune functions after            maternal exposure to 5-fluorouracil during pregnancy in mice. J            Toxicol Sci. 27: 79\u201386.            2002.","DOI":"10.2131\/jts.27.79"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Shuey              DL,                Lau              C,                Logsdon              TR,                Zucker              RM,                Elstein              KH,                Narotsky              MG,                Setzer              RW,                Kavlock              RJ, and                Rogers              JM.            Biologically based dose-response modeling in developmental toxicology:            biochemical and cellular sequelae of 5-fluorouracil exposure in the developing            rat. Toxicol Appl Pharmacol. 126:            129\u2013144. 1994.","DOI":"10.1006\/taap.1994.1099"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Shuey              DL,                Setzer              RW,                Lau              C,                Zucker              RM,                Elstein              KH,                Narotsky              MG,                Kavlock              RJ, and                Rogers              JM. Biological            modeling of 5-fluorouracil developmental toxicity.            Toxicology. 102:          207\u2013213. 1995.","DOI":"10.1016\/0300-483X(95)03049-L"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Lau              C,                Mole              ML,                Copeland              MF,                Rogers              JM,                Kavlock              RJ,                Shuey              DL,                Cameron              AM,                Ellis              DH,                Logsdon              TR,                Merriman              J, and                Setzer              RW. Toward a            biologically based dose-response model for developmental toxicity of 5-fluorouracil in            the rat: acquisition of experimental data. Toxicol Sci.            59: 37\u201348. 2001.","DOI":"10.1093\/toxsci\/59.1.37"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Paskulin              GA,                Gazzola Zen              PR,                de Camargo Pinto              LL,                Rosa              R, and                Graziadio              C. Combined            chemotherapy and teratogenicity. Birth Defects Res A Clin Mol            Teratol. 73: 634\u2013637.            2005.","DOI":"10.1002\/bdra.20180"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Hanaoka              H,                Kubota              T,                Matsui              K,                Kadokura              Y,                Iida              M,                Yamada              Y, and                Moteki              H. A case of            leukoencephalopathy after drip infusion of 5-fluoroirasil          (in Japanese). Pract Odontol.            109: 161\u2013163.          2002.","DOI":"10.5631\/jibirinsuppl1986.2002.Supplement109_161"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Leyder              M,                Laubach              M,                Breugelmans              M,                Keymolen              K,                De Greve              J, and                Foulon              W. Specific            congenital malformations after exposure to cyclophosphamide, epirubicin and            5-fluorouracil during the first trimester of pregnancy. Gynecol            Obstet Invest. 71: 141\u2013144.            2011.","DOI":"10.1159\/000317264"},{"key":"9","unstructured":"9.  Bourke              RS,                West              CR,                Chheda              G, and                Tower              DB. Kinetics of            entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following            intravenous injection in a primate. Cancer Res.            33: 1735\u20131746. 1973."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Han              R,                Yang              YM,                Dietrich              J,                Luebke              A,                Mayer-Pr\u00f6schel              M, and                Noble              M. Systemic            5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central            nervous system. J Biol. 7:            12. 2008.","DOI":"10.1186\/jbiol69"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.  Doi              K. Mechanisms            of neurotoxicity induced in the developing brain of mice and rats by DNA-damaging            chemicals. J Toxicol Sci. 36:            695\u2013712. 2011.","DOI":"10.2131\/jts.36.695"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.  Bejar              A,                Roujansky              P,                de Barry              J, and                Gombos              G. Different            effect of methylazoxymethanol on mouse cerebellar development depending on the age of            injection. Exp Brain Res. 57:            279\u2013285. 1985.","DOI":"10.1007\/BF00236533"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Ohmori              H,                Ogura              H,                Yasuda              M,                Nakamura              S,                Hatta              T,                Kawano              K,                Michikawa              T,                Yamashita              K, and                Mikoshiba              K.            Developmental neurotoxicity of phenytoin on granule cells and Purkinje            cells in mouse cerebellum. J Neurochem.            72: 1497\u20131506. 1999.","DOI":"10.1046\/j.1471-4159.1999.721497.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.  Fritsch              P,                Richard-Le Naour              H,                Denis              S, and                M\u00e9n\u00e9trier              F. Kinetics of            radiation-induced apoptosis in the cerebellum of 14-day-old rats after acute or during            continuous exposure. Int J Radiat Biol.            66: 111\u2013117. 1994.","DOI":"10.1080\/09553009414550991"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.  Pisu              MB,                Roda              E,                Guioli              S,                Avella              D,                Bottone              MG, and                Bernocchi              G.            Proliferation and migration of granule cells in the developing rat            cerebellum: cisplatin effects. Anat Rec A Discov Mol Cell Evol            Biol. 287: 1226\u20131235.            2005.","DOI":"10.1002\/ar.a.20249"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16.  Sugiyama              A,                Sun              J,                Ueda              K,                Furukawa              S, and                Takeuchi              T. Effect of            methotrexate on cerebellar development in infant rats. J Vet Med            Sci. 77: 789\u2013797.            2015.","DOI":"10.1292\/jvms.14-0475"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Ohira              T,                Ando              R,                Saito              T,                Yahata              M,                Oshima              Y, and                Tamura              K.            Busulfan-induced pathological changes of the cerebellar development in            infant rats. Exp Toxicol Pathol. 65:            789\u2013797. 2013.","DOI":"10.1016\/j.etp.2012.11.005"},{"key":"18","unstructured":"18.  Zhang              Y,                Yin              N,                Liang              S,                Shen              S,                Li              D, and                Faiola              F.            5-fluorouracil-induced neurotoxicity in rat cerebellum granule cells            involves oxidative stress and activation of caspase-3 pathway.            Int J Clin Exp Med. 12:            2334\u20132343. 2019."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Yamaguchi              Y,                Fukunaga              Y,                Takagi              M,                Saito              T,                Tamura              K, and                Hoshiya              T. Time-course            changes in 5-fluorouracil-induced neural progenitor cell damages in the developing rat            brain. J Toxicol Pathol. 34:            299\u2013308. 2021.","DOI":"10.1293\/tox.2020-0070"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Chizhikov              V, and                Millen              KJ. Development            and malformations of the cerebellum in mice. Mol Genet            Metab. 80: 54\u201365.            2003.","DOI":"10.1016\/j.ymgme.2003.08.019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Leto              K,                Arancillo              M,                Becker              EB,                Buffo              A,                Chiang              C,                Ding              B,                Dobyns              WB,                Dusart              I,                Haldipur              P,                Hatten              ME,                Hoshino              M,                Joyner              AL,                Kano              M,                Kilpatrick              DL,                Koibuchi              N,                Marino              S,                Martinez              S,                Millen              KJ,                Millner              TO,                Miyata              T,                Parmigiani              E,                Schilling              K,                Sekerkov\u00e1              G,                Sillitoe              RV,                Sotelo              C,                Uesaka              N,                Wefers              A,                Wingate              RJ, and                Hawkes              R. Consensus            paper: cerebellar development. Cerebellum.            15: 789\u2013828. 2016.","DOI":"10.1007\/s12311-015-0724-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.  Uberti              D,                Belloni              M,                Grilli              M,                Spano              P, and                Memo              M. Induction of            tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar            neurones triggered by excitatory amino acids. Eur J            Neurosci. 10: 246\u2013254.            1998.","DOI":"10.1046\/j.1460-9568.1998.00042.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23.  Lakin              ND, and                Jackson              SP. Regulation            of p53 in response to DNA damage. Oncogene.            18: 7644\u20137655. 1999.","DOI":"10.1038\/sj.onc.1203015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  Oren              M. Decision            making by p53: life, death and cancer. Cell Death            Differ. 10: 431\u2013442.            2003.","DOI":"10.1038\/sj.cdd.4401183"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.  Zhang              X-P,                Liu              F, and                Wang              W. Two-phase            dynamics of p53 in the DNA damage response. Proc Natl Acad Sci            USA. 108: 8990\u20138995.            2011.","DOI":"10.1073\/pnas.1100600108"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.  Tsujimoto              Y. Role of            Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?          Genes Cells. 3: 697\u2013707.            1998.","DOI":"10.1046\/j.1365-2443.1998.00223.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.  Leibowitz              B, and                Yu              J.            Mitochondrial signaling in cell death via the Bcl-2            family. Cancer Biol Ther. 9:            417\u2013422. 2010.","DOI":"10.4161\/cbt.9.6.11392"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28.  Yu              J, and                Zhang              L. PUMA, a            potent killer with or without p53. Oncogene.            27(Suppl 1):            S71\u2013S83. 2008.","DOI":"10.1038\/onc.2009.45"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.  Brentnall              M,                Rodriguez-Menocal              L,                De Guevara              RL,                Cepero              E, and                Boise              LH. Caspase-9,            caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis.            BMC Cell Biol. 14: 32.            2013.","DOI":"10.1186\/1471-2121-14-32"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30.  Cryns              V, and                Yuan              J. Proteases to            die for. Genes Dev. 12:            1551\u20131570. 1998.","DOI":"10.1101\/gad.12.11.1551"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31.  Motamedi              Z,                Amini              SA,                Raeisi              E,                Lemoigne              Y, and                Heidarian              E. Combined            effects of protocatechuic acid and 5-fluorouracil on p53 gene expression and apoptosis            in gastric adenocarcinoma cells. Turk J Pharm Sci.            17: 578\u2013585. 2020.","DOI":"10.4274\/tjps.galenos.2019.69335"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32.  Satari              A,                Amini              SA,                Raeisi              E,                Lemoigne              Y, and                Heidarian              E. Synergetic            impact of combined 5-fluorouracil and rutin on apoptosis in PC3 cancer cells through the            modulation of P53 gene expression. Adv Pharm Bull.            9: 462\u2013469. 2019.","DOI":"10.15171\/apb.2019.055"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33.  Hou              J,                Tan              Y,                Su              C,                Wang              T,                Gao              Z,                Song              D,                Zhao              J,                Liao              Y,                Liu              X,                Jiang              Y,                Feng              Q,                Wan              Z, and                Yu              Y. Inhibition            of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma <i>via<\/i>            p53 signaling pathways. Comput Struct Biotechnol J.            18: 125\u2013136. 2019.","DOI":"10.1016\/j.csbj.2019.12.010"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34.  Aquino                Esperanza              JA,                Aguirre              MV,                Aispuru              GR,                Lettieri              CN,                Juaristi              JA,                Alvarez              MA, and                Brandan              NC. In vivo            5-fluorouracil-[corrected]induced apoptosis on murine thymocytes: involvement of FAS,            Bax and Caspase3. Cell Biol Toxicol.            24: 411\u2013422. 2008.","DOI":"10.1007\/s10565-008-9056-z"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35.  Vogelstein              B, and                Kinzler              KW. Cancer            genes and the pathways they control. Nat Med.            10: 789\u2013799. 2004.","DOI":"10.1038\/nm1087"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36.  el-Deiry              WS,                Tokino              T,                Velculescu              VE,                Levy              DB,                Parsons              R,                Trent              JM,                Lin              D,                Mercer              WE,                Kinzler              KW, and                Vogelstein              B. WAF1, a            potential mediator of p53 tumor suppression. Cell.            75: 817\u2013825. 1993.","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37.  Zhang              XP,                Liu              F, and                Wang              W. Coordination            between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in            response to DNA damage. J Biol Chem.            285: 31571\u201331580. 2010.","DOI":"10.1074\/jbc.M110.134650"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38.  Bunz              F,                Dutriaux              A,                Lengauer              C,                Waldman              T,                Zhou              S,                Brown              JP,                Sedivy              JM,                Kinzler              KW, and                Vogelstein              B. Requirement            for p53 and p21 to sustain G2 arrest after DNA damage.            Science. 282: 1497\u20131501.            1998.","DOI":"10.1126\/science.282.5393.1497"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39.  McKay              BE, and                Turner              RW.            Physiological and morphological development of the rat cerebellar            Purkinje cell. J Physiol. 567:            829\u2013850. 2005.","DOI":"10.1113\/jphysiol.2005.089383"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/35\/4\/35_2022-0003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T04:53:53Z","timestamp":1666414433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/35\/4\/35_2022-0003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2022-0003","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022-0003"}}